Learn about Johnson & Johnson’s strength in healthcare innovation
We’re building a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal.
JJ_Launch_60_H264_16x9_Captioned_Adaptive Low Bitrate.mp4
Innovative Medicine
Johnson & Johnson Innovative Medicine is leading where medicine is going. Patients inform and inspire our science-based innovations, which continue to change and save lives. With rigorous science and compassion, we confidently address the most complex diseases of our time and unlock the potential medicines of tomorrow. Therapeutic areas include: Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension, and Retina.
MedTech
Johnson & Johnson MedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex diseases. Focus areas include: Interventional Solutions, Orthopaedics, Surgery and Vision.
Solving the toughest health challenges
Innovation
Innovation
How Johnson & Johnson is advancing new options for bladder cancer treatment
Every year, roughly 80,000 Americans receive a bladder cancer diagnosis. Many endure difficult and burdensome treatments in an attempt to fight the disease. But new innovations just might change that.
5 things we now know about atrial fibrillation
More than 37.5 million people worldwide are affected by this common type of heart arrhythmia—and by 2025, the number of cases will increase by 60%. Learn the facts behind this heart condition, plus one patient’s diagnosis story.
Personal stories
Personal stories
“No one would believe me when I suspected I had lung cancer”
Learn about one patient’s journey toward getting an accurate diagnosis—and why it’s crucial to always advocate for your health.
Health & wellness
Health & wellness
What it’s like when your baby has a rare blood disorder
A condition called fetal and neonatal alloimmune thrombocytopenia (FNAIT) can be deadly in newborns. That’s why Johnson & Johnson is passionate about developing a treatment for the disorder.
Innovation
Innovation
Artificial intelligence is helping revolutionize healthcare as we know it
Advancing drug discovery. Helping treatments reach patients faster. Diversifying clinical trials. Here’s a look at how Johnson & Johnson is harnessing AI to help create a healthier world.
Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way
The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.
